newsfilter
← Latest News
Business Wire·

Immunome Presents Additional Clinical Data for Varegacestat in Desmoid Tumors at ESMO 2026

Rapid oral presentation highlights improvements in patient-reported symptom burden and physical function through week 48 Four presentations build on the previously reported Phase 3 RINGSIDE results Immunome,